The miR-15 family acts as a novel regulator of cardiac hypertrophy and fibrosis through inhibition of the TGFβ-pathway, suggesting a potential therapeutic target.
We identified the miR-15 family as a novel regulator of cardiac hypertrophy and fibrosis acting by inhibition of the TGFβ-pathway.
Tijsen et al. (Thu,) studied this question.